Assessment of the complementary and integrative medicine utilization among patients with multiple sclerosis using a translated and adapted version of the international questionnaire (I-CAM-QP): A cross-sectional study in Southern Iran

被引:12
作者
Farhoudi, Farinaz [1 ,2 ]
Salehi, Alireza [1 ]
Vojoud, Mina [1 ]
Vardanjani, Hossein Molavi [3 ]
机构
[1] Shiraz Univ Med Sci, Res Ctr Tradit Med & Hist Med, Shiraz, Iran
[2] Shiraz Univ Med Sci, Student Res Comm, Shiraz, Iran
[3] Shiraz Univ Med Sci, MPH Dept, Sch Med, Shiraz, Iran
关键词
Complementary and integrative medicine; Complementary and alternative medicine; I-CAM-Q; Iran; Multiple sclerosis; ALTERNATIVE MEDICINE; PREVALENCE; POPULATION; BURDEN; COSTS;
D O I
10.1016/j.ctim.2019.07.016
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Aims: To assess the prevalence of and factors related to complementary and integrative medicine (CIM) use among multiple sclerosis (MS) patients, using a translated and adapted version of a standard international questionnaire. Methods: International complementary and alternative medicine questionnaire (I-CAM-Q) was used. A cross-sectional study was done to assess the prevalence of and factors associated with CIM use among MS patients in Southern Iran. Patients who were randomly selected from MS registry center, were interviewed via phone calls. Results: Three hundred patients were enrolled in the study; 69% of them were female. Their mean age was 36.6 +/- 8.53 years and the mean duration of the disease was 5.6 +/- 4.22 years. In all, 99.3% (95% CI) of the patients had used at least one type of CIM. Herbal medicines and dietary supplements were the most commonly used CIM type (97.3%; 95% CI). Praying was the most common modality among all CIM subgroups (81.3%; 95% CI). Long term illness (MS) was selected as the main reason for the last use of all CIM types. Having non-tertiary education and having sequel due to MS were related to visiting a CIM provider (adjusted odds ratio (AOR) = 2.32, 95% confidence interval (CI) = 1.22-4.43), (AOR = 2.67, 95% CI = 1.47-4.83) respectively. Being female was related to the use of self-help practices (AOR = 3.41, 95% CI = 1.5-7.72). Conclusion: There is a high prevalence of CIM use among MS patients. Therefore, patient- physician communication about CIM use should be emphasized.
引用
收藏
页码:47 / 53
页数:7
相关论文
共 40 条
  • [1] Use of Complementary Therapies for Cancer Symptom Management: Results of the 2007 National Health Interview Survey
    Anderson, Joel G.
    Taylor, Ann Gill
    [J]. JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE, 2012, 18 (03) : 235 - 241
  • [2] [Anonymous], 2013, WHO traditional medicine strategy: -
  • [3] Berg Elisabeth A B, 2014, J Autoimmune Dis Rheumatol, V2, P74
  • [4] ATLAS OF MULTIPLE SCLEROSIS 2013: A GROWING GLOBAL PROBLEM WITH WIDESPREAD INEQUITY
    Browne, Paul
    Chandraratna, Dhia
    Angood, Ceri
    Tremlett, Helen
    Baker, Chris
    Taylor, Bruce V.
    Thompson, Alan J.
    [J]. NEUROLOGY, 2014, 83 (11) : 1022 - 1024
  • [5] Burden of multiple sclerosis on direct, indirect costs and quality of life: National US estimates
    Campbell, Jonathan D.
    Ghushchyan, Vahram
    McQueen, R. Brett
    Cahoon-Metzger, Sharon
    Livingston, Terrie
    Vollmer, Timothy
    Corboy, John
    Miravalle, Augusto
    Schreiner, Teri
    Porter, Victoria
    Nair, Kavita
    [J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2014, 3 (02) : 227 - 236
  • [6] Druart Leo, 2018, Medicines (Basel), V5, DOI 10.3390/medicines5030072
  • [7] Etemadifar M., 2012, INT J PREV MED, V3, P5
  • [8] Epidemiology of Multiple Sclerosis in Iran: A Systematic Review
    Etemadifar, Masoud
    Sajjadi, Sepideh
    Nasr, Zahra
    Firoozeei, Toktam Sadat
    Abtahi, Seyed-Hossein
    Akbari, Mojtaba
    Fereidan-Esfahani, Mahboobeh
    [J]. EUROPEAN NEUROLOGY, 2013, 70 (5-6) : 356 - 363
  • [9] Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015
    Feigin, Valery L.
    Abajobir, Amanuel Alemu
    Abate, Kalkidan Hassen
    Abd-Allah, Foad
    Abdulle, Abdishakur M.
    Abera, Semaw Ferede
    Abyu, Gebre Yitayih
    Ahmed, Muktar Beshir
    Aichour, Amani Nidhal
    Aichour, Ibtihel
    Aichour, Miloud Taki Eddine
    Akinyemi, Rufus Olusola
    Alabed, Samer
    Al-Raddadi, Rajaa
    Alvis-Guzman, Nelson
    Amare, Azmeraw T.
    Ansari, Hossein
    Anwari, Palwasha
    Arnlov, Johan
    Asayesh, Hamid
    Asgedom, Solomon Weldegebreal
    Atey, Tesfay Mehari
    Avila-Burgos, Leticia
    Avokpaho, Euripide Frinel G. Arthur
    Azarpazhooh, Mahmood Reza
    Barac, Aleksandra
    Barboza, Miguel
    Barker-Collo, Suzanne L.
    Baernighausen, Till
    Bedi, Neeraj
    Beghi, Ettore
    Bennett, Derrick A.
    Bensenor, Isabela M.
    Berhane, Adugnaw
    Betsu, Balem Demtsu
    Bhaumik, Soumyadeep
    Birlik, Sait Mentes
    Biryukov, Stan
    Boneya, Dube Jara
    Bulto, Lemma NegesaBulto
    Carabin, Helene
    Casey, Daniel
    Castaneda-Orjuela, Carlos A.
    Catala-Lopez, Ferran
    Chen, Honglei
    Chitheer, Abdulaal A.
    Chowdhury, Rajiv
    Christensen, Hanne
    Dandona, Lalit
    Dandona, Rakhi
    [J]. LANCET NEUROLOGY, 2017, 16 (11) : 877 - 897
  • [10] High prevalence of complementary and alternative medicine use in patients with genetically proven mitochondrial disorders
    Franik, Sebastian
    Huidekoper, Hidde H.
    Visser, Gepke
    de Vries, Maaike
    de Boer, Lonneke
    Hermans-Peters, Marion
    Rodenburg, Richard
    Verhaak, Chris
    Vlieger, Arine M.
    Smeitink, Jan A. M.
    Janssen, Mirian C. H.
    Wortmann, Saskia B.
    [J]. JOURNAL OF INHERITED METABOLIC DISEASE, 2015, 38 (03) : 477 - 482